InsidersTradesSigma
Track the 神州细胞 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 神州细胞 has logged 7 public disclosures. Market capitalisation: €15.7bn. The latest transaction was filed on 5 July 2022 (Purchase). Among the most active insiders: 谢良志. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
神州细胞 is a company focused on the health and pharmaceutical sector, specializing in the development of cell therapies. It is listed on the XSHG market.